Recall events
/
Event 74135
Event summary
Timeline bucket May 11, 2016
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Profarma Distributors LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
5 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 5
tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057
D-1039-2016
Recall number D-1039-2016
Initiated May 11, 2016
Classification Class II
Status Terminated
Quantity 42 boxes (504 capsules)
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations
Code information Lot # 224TS; Exp. 02/17
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8666]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 5
tabcin NOCHE; Capsules,12-count box, UPC 501008485033
D-1040-2016
Recall number D-1040-2016
Initiated May 11, 2016
Classification Class II
Status Terminated
Quantity 31 boxes ( 372 capsules)
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations
Code information Lot # X223FS; Exp. 11/17
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6736]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 5
VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619
D-1041-2016
Recall number D-1041-2016
Initiated May 11, 2016
Classification Class II
Status Terminated
Quantity 163 boxes (978 tablets)
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations
Code information Lot # UPE187; Exp. 08/17
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8691]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 5
VERMOX Tablets 500 mg, 1-count box, UPC 501109900596
D-1042-2016
Recall number D-1042-2016
Initiated May 11, 2016
Classification Class II
Status Terminated
Quantity 254 boxes (254 tablets)
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations
Code information Lot # UJE 040; Exp. 02/17
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8686]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 5
1% Clotrimazol cream, 30 mg tube, UPC 501318644335
D-1043-2016
Recall number D-1043-2016
Initiated May 11, 2016
Classification Class II
Status Terminated
Quantity 79 boxes (79 tubes)
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
CGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall CGMP Deviations
Code information Lot # GRU1390; Exp. 08/17
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8678]
FDA event record
· Exact recall-number query on openFDA
